James Investment Research’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.37M Buy
21,252
+1,006
+5% +$150K 0.34% 70
2026
Q1
$2.97M Sell
20,246
-443
-2% -$68.3K 0.33% 76
2025
Q4
$3.2M Sell
20,689
-583
-3% -$87.3K 0.35% 70
2025
Q3
$2.96M Sell
21,272
-589
-3% -$79.7K 0.32% 77
2025
Q2
$2.95M Sell
21,861
-96
-0.4% -$13K 0.35% 76
2025
Q1
$3.21M Sell
21,957
-3,083
-12% -$448K 0.41% 71
2024
Q4
$3.44M Buy
25,040
+1,158
+5% +$169K 0.41% 67
2024
Q3
$3.68M Buy
23,882
+1,521
+7% +$231K 0.42% 69
2024
Q2
$3.26M Sell
22,361
-240
-1% -$34.4K 0.39% 74
2024
Q1
$3.34M Sell
22,601
-578
-2% -$82.9K 0.4% 77
2023
Q4
$3.16M Sell
23,179
-1,515
-6% -$197K 0.4% 76
2023
Q3
$3.18M Sell
24,694
-930
-4% -$123K 0.42% 73
2023
Q2
$3.4M Sell
25,624
-1,986
-7% -$262K 0.43% 75
2023
Q1
$3.57M Sell
27,610
-1,479
-5% -$193K 0.47% 71
2022
Q4
$3.95M Buy
29,089
+311
+1% +$41.2K 0.55% 62
2022
Q3
$3.48M Sell
28,778
-2,688
-9% -$346K 0.5% 67
2022
Q2
$4.04M Sell
31,466
-155
-0.5% -$20.3K 0.54% 61
2022
Q1
$4.33M Sell
31,621
-2,041
-6% -$270K 0.45% 67
2021
Q4
$4.74M Sell
33,662
-2,032
-6% -$270K 0.43% 69
2021
Q3
$4.54M Sell
35,694
-7,842
-18% -$1.04M 0.42% 73
2021
Q2
$5.48M Sell
43,536
-1,571
-3% -$193K 0.47% 68
2021
Q1
$5.27M Sell
45,107
-3,644
-7% -$421K 0.48% 70
2020
Q4
$5.53M Sell
48,751
-7,068
-13% -$772K 0.5% 70
2020
Q3
$5.89M Sell
55,819
-9,136
-14% -$962K 0.54% 55
2020
Q2
$6.5M Sell
64,955
-2,052
-3% -$203K 0.61% 53
2020
Q1
$5.94M Buy
67,007
+1,689
+3% +$164K 0.61% 55
2019
Q4
$6.65M Buy
65,318
+758
+1% +$72.9K 0.46% 73
2019
Q3
$5.82M Sell
64,560
-15,114
-19% -$1.38M 0.42% 75
2019
Q2
$7.38M Sell
79,674
-27,364
-26% -$2.46M 0.54% 55
2019
Q1
$9.82M Buy
107,038
+52,106
+95% +$4.7M 0.64% 41
2018
Q4
$4.75M Buy
54,932
+51,677
+1,588% +$4.68M 0.3% 88
2018
Q3
$310K Buy
3,255
+70
+2% +$6.32K 0.01% 548
2018
Q2
$266K Hold
3,185
0.01% 566
2018
Q1
$259K Hold
3,185
0.01% 554
2017
Q4
$263K Sell
3,185
-240
-7% -$19.8K 0.01% 558
2017
Q3
$280K Buy
3,425
+3,275
+2,183% +$263K 0.01% 519
2017
Q2
$12K Buy
+150
New +$11.4K ﹤0.01% 689
2014
Q3
Sell
-300
Closed -$18K 543
2014
Q2
$18K Sell
300
-2,000
-87% -$118K ﹤0.01% 445
2014
Q1
$135K Hold
2,300
﹤0.01% 341
2013
Q4
$128K Sell
2,300
-695
-23% -$37.2K ﹤0.01% 334
2013
Q3
$151K Hold
2,995
0.01% 313
2013
Q2
$143K Buy
+2,995
New +$143K 0.01% 316

Other funds holding XLV

James Investment Research's XLV Position: Q2 2026 in Review

James Investment Research increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 5% in Q2 2026, buying an estimated $150K and bringing the position to 21,252 shares worth $3.37M. The position accounts for 0.34% of the portfolio, ranked #70.

James Investment Research first reported a position in XLV in Q2 2013 and has held it in 42 quarters since. The position peaked at $9.82M in Q1 2019. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • James Investment Research held 21,252 shares of State Street Health Care Select Sector SPDR ETF worth $3.37M as of Q2 2026.
  • James Investment Research bought 1,006 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $150K.
  • State Street Health Care Select Sector SPDR ETF made up 0.34% of James Investment Research's portfolio in Q2 2026, its #70 holding.
  • James Investment Research first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 42 quarters since.
  • James Investment Research's State Street Health Care Select Sector SPDR ETF position peaked at $9.82M in Q1 2019.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.